

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Update on ventilator-associated pneumonia | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2061/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2061" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Update on ventilator-associated pneumonia" />
    
            <meta name="og:title" content="F1000Research Article: Update on ventilator-associated pneumonia.">
            <meta name="og:description" content="Read the latest article version by Jean-Francois Timsit, Wafa Esaied, Mathilde Neuville, Lila Bouadma, Bruno Mourvillier, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13232">
            <meta name="article-id" content="12222">
            <meta name="dc.title" content="Update on ventilator-associated pneumonia">
            <meta name="dc.description" content="Ventilator-associated pneumonia (VAP) is the most frequent life-threatening nosocomial infection in intensive care units. The diagnostic is difficult because radiological and clinical signs are inaccurate and could be associated with various respiratory diseases. The concept of infection-related ventilator-associated complication has been proposed as a surrogate of VAP to be used as a benchmark indicator of quality of care. Indeed, bundles of prevention measures are effective in decreasing the VAP rate. In case of VAP suspicion, respiratory secretions must be collected for bacteriological secretions before any new antimicrobials. Quantitative distal bacteriological exams may be preferable for a more reliable diagnosis and therefore a more appropriate use antimicrobials. To improve the prognosis, the treatment should be adequate as soon as possible but should avoid unnecessary broad-spectrum antimicrobials to limit antibiotic selection pressure. For empiric treatments, the selection of antimicrobials should consider the local prevalence of microorganisms along with their associated susceptibility profiles. Critically ill patients require high dosages of antimicrobials and more specifically continuous or prolonged infusions for beta-lactams. After patient stabilization, antimicrobials should be maintained for 7&ndash;8 days. The evaluation of VAP treatment based on 28-day mortality is being challenged by regulatory agencies, which are working on alternative surrogate endpoints and on trial design optimization.">
            <meta name="dc.subject" content="ventilator-associated pneumonia, VAP, nosocomial infection, antimicrobials ">
            <meta name="dc.creator" content="Timsit, Jean-Francois">
            <meta name="dc.creator" content="Esaied, Wafa">
            <meta name="dc.creator" content="Neuville, Mathilde">
            <meta name="dc.creator" content="Bouadma, Lila">
            <meta name="dc.creator" content="Mourvillier, Bruno">
            <meta name="dc.date" content="2017/11/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12222.1">
            <meta name="dc.source" content="F1000Research 2017 6:2061">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="ventilator-associated pneumonia">
            <meta name="prism.keyword" content="VAP">
            <meta name="prism.keyword" content="nosocomial infection">
            <meta name="prism.keyword" content="antimicrobials ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/11/29">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2061">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12222.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2061">
            <meta name="citation_title" content="Update on ventilator-associated pneumonia">
            <meta name="citation_abstract" content="Ventilator-associated pneumonia (VAP) is the most frequent life-threatening nosocomial infection in intensive care units. The diagnostic is difficult because radiological and clinical signs are inaccurate and could be associated with various respiratory diseases. The concept of infection-related ventilator-associated complication has been proposed as a surrogate of VAP to be used as a benchmark indicator of quality of care. Indeed, bundles of prevention measures are effective in decreasing the VAP rate. In case of VAP suspicion, respiratory secretions must be collected for bacteriological secretions before any new antimicrobials. Quantitative distal bacteriological exams may be preferable for a more reliable diagnosis and therefore a more appropriate use antimicrobials. To improve the prognosis, the treatment should be adequate as soon as possible but should avoid unnecessary broad-spectrum antimicrobials to limit antibiotic selection pressure. For empiric treatments, the selection of antimicrobials should consider the local prevalence of microorganisms along with their associated susceptibility profiles. Critically ill patients require high dosages of antimicrobials and more specifically continuous or prolonged infusions for beta-lactams. After patient stabilization, antimicrobials should be maintained for 7&ndash;8 days. The evaluation of VAP treatment based on 28-day mortality is being challenged by regulatory agencies, which are working on alternative surrogate endpoints and on trial design optimization.">
            <meta name="citation_description" content="Ventilator-associated pneumonia (VAP) is the most frequent life-threatening nosocomial infection in intensive care units. The diagnostic is difficult because radiological and clinical signs are inaccurate and could be associated with various respiratory diseases. The concept of infection-related ventilator-associated complication has been proposed as a surrogate of VAP to be used as a benchmark indicator of quality of care. Indeed, bundles of prevention measures are effective in decreasing the VAP rate. In case of VAP suspicion, respiratory secretions must be collected for bacteriological secretions before any new antimicrobials. Quantitative distal bacteriological exams may be preferable for a more reliable diagnosis and therefore a more appropriate use antimicrobials. To improve the prognosis, the treatment should be adequate as soon as possible but should avoid unnecessary broad-spectrum antimicrobials to limit antibiotic selection pressure. For empiric treatments, the selection of antimicrobials should consider the local prevalence of microorganisms along with their associated susceptibility profiles. Critically ill patients require high dosages of antimicrobials and more specifically continuous or prolonged infusions for beta-lactams. After patient stabilization, antimicrobials should be maintained for 7&ndash;8 days. The evaluation of VAP treatment based on 28-day mortality is being challenged by regulatory agencies, which are working on alternative surrogate endpoints and on trial design optimization.">
            <meta name="citation_keywords" content="ventilator-associated pneumonia, VAP, nosocomial infection, antimicrobials ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Jean-Francois Timsit">
            <meta name="citation_author_institution" content="Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France">
            <meta name="citation_author_institution" content="IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France">
            <meta name="citation_author" content="Wafa Esaied">
            <meta name="citation_author_institution" content="IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France">
            <meta name="citation_author" content="Mathilde Neuville">
            <meta name="citation_author_institution" content="Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France">
            <meta name="citation_author" content="Lila Bouadma">
            <meta name="citation_author_institution" content="Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France">
            <meta name="citation_author_institution" content="IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France">
            <meta name="citation_author" content="Bruno Mourvillier">
            <meta name="citation_author_institution" content="Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France">
            <meta name="citation_author_institution" content="IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France">
            <meta name="citation_publication_date" content="2017/11/29">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2061">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12222.1">
            <meta name="citation_firstpage" content="2061">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2061/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2061.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13232 /> <input type=hidden id=articleId name=articleId value=12222 /> <input type=hidden id=xmlUrl value="/articles/6-2061/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2061-v1.xml"> <input type=hidden id=article_uuid value=8f44c118-e840-42de-a2a0-d50f99c85a16 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Update on ventilator-associated pneumonia"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12222.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12222.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2061"
  },
  "headline": "Update on ventilator-associated pneumonia",
  "datePublished": "2017-11-29T10:50:06",
  "dateModified": "2017-11-29T10:50:06",
  "author": [
    {
      "@type": "Person",
      "name": "Jean-Francois Timsit"
    },    {
      "@type": "Person",
      "name": "Wafa Esaied"
    },    {
      "@type": "Person",
      "name": "Mathilde Neuville"
    },    {
      "@type": "Person",
      "name": "Lila Bouadma"
    },    {
      "@type": "Person",
      "name": "Bruno Mourvillier"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Ventilator-associated pneumonia (VAP) is the most frequent life-threatening nosocomial infection in intensive care units. The diagnostic is difficult because radiological and clinical signs are inaccurate and could be associated with various respiratory diseases. The concept of infection-related ventilator-associated complication has been proposed as a surrogate of VAP to be used as a benchmark indicator of quality of care. Indeed, bundles of prevention measures are effective in decreasing the VAP rate. In case of VAP suspicion, respiratory secretions must be collected for bacteriological secretions before any new antimicrobials. Quantitative distal bacteriological exams may be preferable for a more reliable diagnosis and therefore a more appropriate use antimicrobials. To improve the prognosis, the treatment should be adequate as soon as possible but should avoid unnecessary broad-spectrum antimicrobials to limit antibiotic selection pressure. For empiric treatments, the selection of antimicrobials should consider the local prevalence of microorganisms along with their associated susceptibility profiles. Critically ill patients require high dosages of antimicrobials and more specifically continuous or prolonged infusions for beta-lactams. After patient stabilization, antimicrobials should be maintained for 7&ndash;8 days. The evaluation of VAP treatment based on 28-day mortality is being challenged by regulatory agencies, which are working on alternative surrogate endpoints and on trial design optimization."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2061.html",
            "name": "Update on ventilator-associated pneumonia"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Update on ventilator-associated pneumonia </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13232 data-id=12222 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12222.1" data-recommended="" data-doi="10.12688/f1000research.12222.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2061/v1/pdf?article_uuid=8f44c118-e840-42de-a2a0-d50f99c85a16" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12222-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12222-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12222-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Timsit JF, Esaied W, Neuville M <em>et al.</em> Update on ventilator-associated pneumonia [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2061 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12222.1" target=_blank>https://doi.org/10.12688/f1000research.12222.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12222-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12222 id=track-article-signin-12222 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12222?target=/articles/6-2061.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13232 /> <input name=articleId type=hidden value=12222 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Update on ventilator-associated pneumonia</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:jean-francois.timsit@bch.aphp.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jean-Francois Timsit</span></a><a href="https://orcid.org/0000-0002-6063-7383" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6063-7383</div><sup>1,2</sup>,&nbsp;</span><span class="">Wafa Esaied<sup>1</sup>,&nbsp;</span><span class="">Mathilde Neuville<sup>2</sup>,&nbsp;</span><span class="">Lila Bouadma<sup>1,2</sup>,&nbsp;</span><span class="">Bruno Mourvillier<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:jean-francois.timsit@bch.aphp.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jean-Francois Timsit</span></a><a href="http://orcid.org/0000-0002-6063-7383" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6063-7383</div><sup>1,2</sup>,&nbsp;</span><span class="">Wafa Esaied<sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Mathilde Neuville<sup>2</sup>,&nbsp;</span><span class="">Lila Bouadma<sup>1,2</sup>,&nbsp;</span><span class="">Bruno Mourvillier<sup>1,2</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Nov 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12222.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France<br/> <sup>2</sup> Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France<br/> <p> <div class=margin-bottom> Jean-Francois Timsit <br/> <span>Roles: </span> Conceptualization, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Wafa Esaied <br/> <span>Roles: </span> Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Mathilde Neuville <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Lila Bouadma <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Bruno Mourvillier <br/> <span>Roles: </span> Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28432-28401></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28431-28400></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Ventilator-associated pneumonia (VAP) is the most frequent life-threatening nosocomial infection in intensive care units. The diagnostic is difficult because radiological and clinical signs are inaccurate and could be associated with various respiratory diseases. The concept of infection-related ventilator-associated complication has been proposed as a surrogate of VAP to be used as a benchmark indicator of quality of care. Indeed, bundles of prevention measures are effective in decreasing the VAP rate. In case of VAP suspicion, respiratory secretions must be collected for bacteriological secretions before any new antimicrobials. Quantitative distal bacteriological exams may be preferable for a more reliable diagnosis and therefore a more appropriate use antimicrobials. To improve the prognosis, the treatment should be adequate as soon as possible but should avoid unnecessary broad-spectrum antimicrobials to limit antibiotic selection pressure. For empiric treatments, the selection of antimicrobials should consider the local prevalence of microorganisms along with their associated susceptibility profiles. Critically ill patients require high dosages of antimicrobials and more specifically continuous or prolonged infusions for beta-lactams. After patient stabilization, antimicrobials should be maintained for 7–8 days. The evaluation of VAP treatment based on 28-day mortality is being challenged by regulatory agencies, which are working on alternative surrogate endpoints and on trial design optimization. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> ventilator-associated pneumonia, VAP, nosocomial infection, antimicrobials </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Jean-Francois Timsit (<a href="mailto:jean-francois.timsit@bch.aphp.fr">jean-francois.timsit@bch.aphp.fr</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Jean-Francois Timsit </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> J-FT gave lectures for Merck, Pfizer, and Gilead on antimicrobial therapy and participated in scientific boards of Paratek, Bayer, Merck, and 3M. The other authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Timsit JF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Timsit JF, Esaied W, Neuville M <em>et al.</em> Update on ventilator-associated pneumonia [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2061 (<a href="https://doi.org/10.12688/f1000research.12222.1" target=_blank>https://doi.org/10.12688/f1000research.12222.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2061 (<a href="https://doi.org/10.12688/f1000research.12222.1" target=_blank>https://doi.org/10.12688/f1000research.12222.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2061 (<a href="https://doi.org/10.12688/f1000research.12222.1" target=_blank>https://doi.org/10.12688/f1000research.12222.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e214>Introduction</h2><p class="" id=d24269e217>Hospital-acquired pneumonia (HAP) is defined by an infection of the lung parenchyma that occurred at least 48 hours after hospital admission. Ventilator-associated pneumonia (VAP) develops in intensive care unit (ICU) patients mechanically ventilated for at least 48 hours<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. In contrast, ventilator-associated tracheobronchitis (VAT) is characterized by signs of respiratory infection without new radiographic infiltrates in a patient mechanically ventilated for at least 48 hours<sup><a href="#ref-3">3</a>–<a href="#ref-5">5</a></sup>.</p><p class="" id=d24269e234>In the past 10 years, a great deal of progress has been made in understanding VAP. New concepts of infection-related ventilator-associated complications (IVACs) and ventilator-associated events (VAEs) have been proposed as outcome indicators for prevention strategies<sup><a href="#ref-6">6</a></sup>. In diagnostic strategies, criteria used to suspect a VAP have been challenged, as have optimal diagnostic tests used to confirm it<sup><a href="#ref-7">7</a></sup>. Traditional risk factors of VAP due to multidrug-resistant (MDR) bacteria (based on early-onset occurrence and previous antimicrobial therapy) are no longer sufficient. Proposed empirical therapy has been modified accordingly. The optimization of pharmacokinetic/pharmacodynamic parameters is now considered a key factor to ensure adequate and successful therapy. The use of adjunctive aerosolized therapy is also more and more debated. In addition, regulatory agencies are trying to find surrogate endpoints to replace 28-day mortality and to improve the design of randomized clinical trials in this field of investigation<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d24269e249>For VAP prevention, the concept of bundle of care was defined. It enabled great successes in VAP prevention; however, the insufficient compliance observed in clinical practice needs to be addressed in order to define easier-to-apply procedures.</p><p class="" id=d24269e252>This review aims to summarize the available knowledge on VAP, taking profit from the recent publication of North American<sup><a href="#ref-7">7</a></sup> and European guidelines on VAP management and highlighting recent advances and remaining controversies of the new concepts.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e262>Epidemiology</h2><p class="" id=d24269e265>VAP is the second most common nosocomial infection and the leading cause of death from nosocomial infections in critically ill patients<sup><a href="#ref-9">9</a></sup>. Its incidence ranges from 5% to 67% depending on case mix and the diagnostic criteria used<sup><a href="#ref-10">10</a></sup>, and the highest rates are in immunocompromised, surgical, and elderly patients. In the US, the incidence of VAP ranges from 2 to 16 episodes per 1,000 ventilator-days<sup><a href="#ref-11">11</a></sup>. The estimated risk of VAP is 1.5% per day and decreases to less than 0.5% per day after the 14th day of mechanical ventilation<sup><a href="#ref-12">12</a></sup>. VAP increases the duration of hospitalization by 7 days and health-care costs by approximately $40,000 USD<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d24269e288>In published studies, the crude mortality of patients with VAP is highly variable according to case mix and definitions used<sup><a href="#ref-14">14</a>–<a href="#ref-16">16</a></sup>. The definition of attributable VAP mortality is the percentage of deaths that would not have occurred in the absence of the infection. Recent studies have reappraised the impact of VAP on mortality<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>. Specifically, given that the risk of VAP is time-dependent, this could potentially result in a significant time-dependent bias because mortality and ICU discharge both act as competing endpoints. Indeed, the most recent studies reported an attributable mortality below 10% with surgical patients<sup><a href="#ref-18">18</a></sup> whereas those with mid-range illness severity presented the highest associated risk<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>.</p><p class="" id=d24269e316>Late-onset VAP is often reported to be associated with higher mortality rates than early-onset VAP<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>. Using a multistate model, we confirmed that the attributable mortality for early-onset VAP (5.8%) was considerably lower than for late-onset VAP (10.6%)<sup><a href="#ref-18">18</a></sup>.</p><p class="" id=d24269e330>Most studies showed that VAP is usually due to aerobic <i>Enterobacteriaceae</i> (25%), <i>Staphylococcus aureus</i> (20%), <i>Pseudomonas aeruginosa</i> (20%), <i>Haemophilus influenza</i> (10%), and streptococci<sup><a href="#ref-23">23</a></sup>. MDR pathogens are more common among late-onset cases. Trouillet <i>et al</i>.<sup><a href="#ref-24">24</a></sup> found that prior use of broad-spectrum antibiotics and mechanical ventilation of more than 7 days were independent risk factors of infection caused by MDR pathogens. However, more recent reports<sup><a href="#ref-25">25</a>–<a href="#ref-29">29</a></sup> have identified similar rates of etiologies in patients with early- versus late-onset VAP. This may be related to the worldwide rise in MDR pathogens; it emphasizes that the local ICU ecology<sup><a href="#ref-30">30</a></sup> is the most important risk factor for acquiring MDR pathogens, irrespective of the length of intubation. In early-onset pneumonia, the initial VAP severity—that is, the presence of sepsis or septic shock (odds ratio [OR] = 3.7)—and pneumonia that developed in a center with a prevalence of resistant pathogens greater than 25% were independently associated with the presence of resistant pathogens (OR = 11.3)<sup><a href="#ref-26">26</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e375>Risk factors of ventilator-associated pneumonia</h2><p class="" id=d24269e378>VAP results from the microbial invasion of the normally sterile lower respiratory tract, which subsequently can overwhelm the host’s defense and establish infection. The major route for microbial invasion is microaspiration of oropharyngeal secretions contaminated by endogenous flora around the endotracheal tube cuff<sup><a href="#ref-31">31</a></sup>. VAP may also occur by other means<sup><a href="#ref-2">2</a>,<a href="#ref-32">32</a></sup>. In terms of potential reservoirs, it has been suggested that the stomach hosts bacteria that colonize the oropharynx. It has been postulated by some researchers that embolization into the alveoli during suctioning or bronchoscopy is caused by the colonization of the endotracheal tube with bacteria encased in a biofilm<sup><a href="#ref-33">33</a></sup>. Inhalation of pathogens from contaminated aerosols and direct inoculation are less common, and hematogenous spread from either infected intravascular catheters or bacterial translocation of the gastrointestinal tract lumen are rarer in occurrence.</p><p class="" id=d24269e396>Consequently, two groups of risk factors for VAP have been identified—namely ventilation-related factors (instrumentation of the airway with an endotracheal tube and subsequent microaspirations) and, less frequently, patient-related factors (for example, pre-existing pulmonary disease)—and only the former is accessible to prevention (<a href="#T1">Table 1</a>). As a result, VAP, unlike many other nosocomial infections, is difficult to prevent<sup><a href="#ref-34">34</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Risk factors of ventilator-associated pneumonia.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24269e417 class=n-a></a><thead><a name=d24269e419 class=n-a></a><tr><a name=d24269e421 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d24269e423 class=n-a></a>Host-related risk factors</th><th align=left colspan=1 rowspan=1><a name=d24269e426 class=n-a></a>Intervention-related risk factors</th></tr></thead><tbody><a name=d24269e431 class=n-a></a><tr><a name=d24269e433 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d24269e434 class=n-a></a>Medical history and underlying illness<br class=br>Male gender<br class=br>Extreme age<br class=br>Prior central nervous system disorder<br class=br>Immunocompromised<br class=br>Acute underlying diseases<br class=br>Emergent surgery<br class=br>Neurosurgery<br class=br>Thoracic surgery<br class=br>Cardiac surgery<br class=br>Burns<br class=br>Re-intervention<br class=br>Acute severity factors<br class=br>Organ system failure index of at least 3<br class=br>Acute renal failure<br class=br>Acute respiratory distress syndrome<br class=br>ECMO, intra-aortic support<br class=br>Ulcer disease</td><td colspan=1 rowspan=1 valign=top><a name=d24269e473 class=n-a></a>Peri-operative transfusion of blood products<br class=br>Duration of the mechanical ventilation<br class=br>Reintubation<br class=br>Supine head position in patients receiving enteral nutrition<br class=br>Antibiotic therapy<sup><a href="#fn1">a</a></sup><br class=br>Enteral nutrition<br class=br>Absence of subglottic secretion drainage<sup><a href="#fn1">b</a></sup><br class=br>Intra-hospital transports<br class=br>Continuous sedation, use of paralytic agents<br class=br>Nasogastric tubes<br class=br>Tracheostomy<br class=br>Frequent ventilator circuit changes<br class=br>Intracuff pressure of less than 20 cm H<sub>2</sub>O</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d24269e515 class=n-a></a><p id=fn1> Adapted from <a href="#ref-2">2</a>,<a href="#ref-35">35</a>–<a href="#ref-38">38</a>. <sup>a</sup>Antibiotic therapy protects from early-onset pneumonia due to susceptible bacteria but is a risk factor for late-onset pneumonia due to more resistant organisms. <sup>b</sup>Protective impact of subglottic secretion drainage is mainly demonstrated for cardiac surgery patients. ECMO, extra-corporeal membrane oxygenation.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e539>Prevention</h2><p class="" id=d24269e542>First of all, reducing the exposure to risk factors for VAP is the most efficient way to prevent VAP onset (<a href="#f1">Figure 1</a>). Therefore, intubation should be avoided whenever possible, and strategies such as non-invasive positive-pressure ventilation, sedation, and weaning protocols should be used to replace or shorten mechanical ventilation. In contrast, recent data suggest that the timing of the tracheotomy does not significantly change VAP incidence<sup><a href="#ref-40">40</a>–<a href="#ref-43">43</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure1.gif"><img alt="6a79512e-456d-41a0-80fe-91b69e7b9d99_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure1.gif"></a><div class=caption><h3>Figure 1. Preventive measures of ventilator-associated pneumonia.</h3><p id=d24269e565>Adapted from <a href="#ref-37">37</a>,<a href="#ref-39">39</a>. QOE, quality of evidence.</p></div></div><p class="" id=d24269e578>Patients at risk of VAP must be managed with a “bundle of preventive measures” (<a href="#f1">Figure 1</a>). Indeed, no single preventive strategy will efficiently prevent VAP. Bundles group together a small straightforward set of key interventions that are from evidence-based guidelines—generally three to five—and that are expected to result in a better outcome when performed collectively and reliably instead of individually. However, the ideal set of key preventive measures is unknown<sup><a href="#ref-44">44</a></sup>. Importantly, although studies demonstrated great success in reducing VAP rates using bundle of care in recent years<sup><a href="#ref-44">44</a>–<a href="#ref-48">48</a></sup>, meta-analyses showed that most of the preventive measures failed to demonstrate a sustained effect<sup><a href="#ref-49">49</a></sup>. This conclusion is in line with the absence of substantial improvement of VAP rates in the past decade<sup><a href="#ref-50">50</a></sup>. <a href="#f1">Figure 1</a> lists recommended preventive measures according to their level of evidence.</p><p class="" id=d24269e607>The sole preventive measures that positively impacted mortality are selective digestive decontamination (SDD) and selective oropharyngeal decontamination (SOD)<sup><a href="#ref-51">51</a></sup>. Compared with SOD, SDD was associated with a lower mortality, reduced length of stay, lower rates of ICU-acquired bacteremia and candidemia, and lower prevalence of rectal carriage of antibiotic-resistant Gram-negative bacteria but with a pronounced gradual increase in aminoglycoside-resistant Gram-negative bacteria<sup><a href="#ref-52">52</a></sup>. The main remaining question is the reproducibility of these results out of the Netherlands. Indeed, the antibiotic selection pressure induced by SOD or SDD may outweigh their benefits in countries with high levels of bacterial resistance.</p><p class="" id=d24269e619>Oral care with chlorhexidine is also debated. An updated meta-analysis focusing on double-blind studies in non-cardiac surgery patients showed that it had no impact on VAP rates or duration of mechanical ventilation or duration of ICU stay<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d24269e626>Ecological Effects of Decolonization Strategies in Intensive Care (RGNOSIS), a cluster-randomized study (ClinicalTrials.gov identifier NCT02208154) conducted in six European countries, is currently enrolling 10,800 patients into four arms: control, oral care with chlorhexidine, SOD, and SDD. The study’s new insights into these ongoing debates are awaited.</p><p class="" id=d24269e629>Many possible factors may explain why prevention measures did not result in reductions in mortality, duration of stay, or antibiotic consumption. First of all, the VAP definition may not be sufficiently accurate, especially when tested intervention could not be blinded. Second, in recent studies using modern statistics, the attributable mortality of VAP is only 3–4%, considerably smaller than previously reported<sup><a href="#ref-19">19</a></sup>. Both factors may induce a dramatic decrease of the power of the studies available.</p><p class="" id=d24269e636>Even if there is convincing evidence that specific interventions might prevent VAP, translating research into practice remains a challenge (<a href="#f1">Figure 1</a>). Two European surveys found that 37.0% of ICU physicians<sup><a href="#ref-54">54</a></sup> and 22.3% of nurses<sup><a href="#ref-55">55</a></sup> did not comply with the published recommendations for VAP prevention. Beyond the theoretical frame, a great deal of attention must be given to the factors that might facilitate a bundle implementation and allow a sustained compliance. An educational session alone, without an associated behavioral strategy, is unlikely to induce profound behavioral changes. It should be kept in mind that, to engage an individual in a particular behavior and improve compliance, we need to act on predisposing factors (knowledge, perceptions, and beliefs) to favor the access to new processes or technologies and to continually reinforce the behavior by feedback<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e660>Diagnosis</h2><div class=section><a name=d24269e663 class=n-a></a><h3 class=section-title>VAP, VAE, IVAC, and VAT: what do these abbreviations mean?</h3><p class="" id=d24269e668>The diagnosis of VAP is traditionally based on clinical symptoms and radiographic criteria that require further bacteriological confirmation. However, it has been demonstrated that these criteria are inaccurate<sup><a href="#ref-14">14</a>,<a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>. Of note, VAP is now considered an indicator of performance in the US and some other countries. The National Healthcare Society Network reported a considerable decrease in the VAP incidence rate attributed to a multifaceted infection control program and its effective implementation<sup><a href="#ref-60">60</a></sup>. A 70% decrease of the incidence between 2006 and 2012 was reported by the Centers for Disease Control and Prevention (CDC). But in the same period, the Medicare Patient Safety Monitoring System reported an adjusted average annual change of 0% (95% confidence interval (CI) −0.05 to 0.07) in patients 65 years old or older<sup><a href="#ref-50">50</a></sup>. These findings emphasize a true discrepancy between rates reported in a quality monitoring program and rates observed in patients’ care program.</p><p class="" id=d24269e689>The discrepancies between results prompted the CDC to promote new objectives of the surveillance based on VAEs. Another important motivation of the CDC was to expand the purview of quality and safety surveillance to encompass multiple complications in mechanically ventilated patients instead of just pneumonia alone. </p><p class="" id=d24269e692>The VAE surveillance definition algorithm uses three new indicators: ventilator-associated complications (VACs), IVACs, and possible and probable VAP<sup><a href="#ref-61">61</a></sup>. VAC is the first step of VAE surveillance, with the aim of identifying any complication occurring in mechanically ventilated patients, regardless of the origin or mechanism. To meet the definition of VAC, a mechanically ventilated patient must have at least 2 days of stability or improvement of respiratory parameters—such as a stable or decreasing daily minimum positive end-expiratory pressure (PEEP) or fraction of inspired oxygen (FiO<sub>2</sub>)—followed by at least 2 days of worsened oxygenation (diagnosed by an increase of the daily minimum PEEP (at least 3 cm H<sub>2</sub>O) or FiO<sub>2</sub> (at least 20%)). The concept of IVAC aims to identify the subgroup of VACs that are potentially related to infection. A VAC associated with an abnormal white blood cell count or a modified temperature becomes an IVAC if the initiation of a new antimicrobial agent is maintained for at least 4 days. With evidence of purulent respiratory secretions or positive results of microbiological tests performed on respiratory tract specimens or both, an IVAC becomes a possible VAP. All of these definitions are summarized in <a href="#f2">Figure 2</a>.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure2.gif"><img alt="6a79512e-456d-41a0-80fe-91b69e7b9d99_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure2.gif"></a><div class=caption><h3>Figure 2. Ventilator-associated events, definitions, and nosology.</h3><p id=d24269e721> <i>Ventilator-associated conditions (VACs)</i>: at least 2 calendar days of stable or decreasing daily minimum positive end-expiratory pressure (PEEP) or fraction of inspired oxygen (FiO<sub>2</sub>) followed by rise in PEEP of at least 3 cm H<sub>2</sub>O or rise in FiO<sub>2</sub> of at least 20 points sustained for at least 2 days. <i>Infection-related ventilator-associated complications (IVACs)</i>: VAC plus: temperature of less than 36°C or more than 38°C OR white blood cell (WBC) count of not more than 4 or at least 12 × 10<sup>3</sup> cells/mm<sup>3</sup> AND at least one new antibiotics continued for at least 4 days WITHIN 2 days of VAC onset EXCLUDING first 2 days on the ventilator. <i>Possible ventilator-associated pneumonia <b></b>(VAP) (Centers for Disease Control and Prevention [CDC] definitions)</i>: IVAC plus: criterion 1: Positive culture meeting specific quantitative or semi-quantitative threshold; criterion 2: Purulent respiratory secretions AND identification of organisms NOT meeting the quantitative or semi-quantitative thresholds; criterion 3: Organisms identified from pleural fluid specimen, positive lung histopathology, and positive diagnostic test for Legionella species or selected respiratory viruses WITHIN 2 days of VAC onset EXCLUDING first 2 days on the ventilator. (The updated January 2017 definitions and comprehensive examples are detailed in the CDC National Healthcare Society Network website; <a target=xrefwindow href="https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf" id=d24269e750>https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf</a>; accessed 23 October 2017.) <i>VAP</i>: radiographic criteria (new or progressive and persistent infiltrates or consolidation or cavitation); systemic criteria (temperature of less than 36°C or more than 38°C OR WBC count of not more than 4 or at least 12 × 10<sup>3</sup> cells/mm<sup>3</sup>); pulmonary criteria (at least one of the following: (1) new onset or increase of purulent aspirates and (2) worsening gas exchange). <i>Ventilator-associated tracheobronchitis (VAT)</i>: criteria for VAP but without radiographic criteria.</p></div></div><p class="" id=d24269e772>The VAE concept uses objective criteria and their collection can be automated for systematic recording. The VAP definition is still widely discussed, and a recent study showed that applying the various diagnostic criteria to the same patient population resulted in large differences in the incidence of VAP (that is, from 4% to 42%)<sup><a href="#ref-62">62</a></sup>. Furthermore, even distal quantitative samples are not 100% reproducible<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>.</p><p class="" id=d24269e786>This new approach might overcome the inaccuracy of the VAP definition, facilitate its electronic assessment, and make inter-ICU comparisons more relevant. Second, the association between VAE and antibiotic consumption (considering VAC rates and not only IVAC) was a point in favor of using VAC rate as one indicator of ICU quality of care for antimicrobial stewardship programs<sup><a href="#ref-12">12</a></sup>. Of note, VAE has very low sensitivity and specificity in diagnosing VAP<sup><a href="#ref-12">12</a></sup>. In our experience, VAP accounted for only 14.5% of the VAC episodes and 27.6% of the IVAC episodes<sup><a href="#ref-12">12</a></sup>; in addition, not all IVAC episodes were related to a nosocomial infection.</p><p class="" id=d24269e801>Furthermore, radiological criteria are not taken into account, so that the IVAC definition includes VAT and VAP (<a href="#f2">Figure 2</a>). Although VAP and VAT are both associated with an increased duration of mechanical ventilation, VAP impact on ICU mortality is higher than that of VAT<sup><a href="#ref-27">27</a></sup>. Finally, embedding VAP in the larger definition of IVAC may hamper the understanding of VAP pathophysiology and thus its prevention improvement.</p></div><div class=section><a name=d24269e812 class=n-a></a><h3 class=section-title>Which bacteriological samples should be collected in case of suspicion of ventilator-associated pneumonia?</h3><p class="" id=d24269e817>Great controversies persist about the bacteriological samples that should be used for diagnosing VAP. Of note, when bacteriological analyses are not immediately available, processing of a bacteriological specimen refrigerated after collection is a reliable alternative<sup><a href="#ref-65">65</a></sup>. Invasive techniques, such as bronchoalveolar lavage or protected specimen brush with quantitative culture, require qualified clinicians. Randomized studies that have evaluated their value as compared with proximal qualitative samples yielded contradictory results<sup><a href="#ref-66">66</a>–<a href="#ref-68">68</a></sup>. In one study with 413 patients<sup><a href="#ref-67">67</a></sup>, the invasive distal quantitative strategy was combined with an algorithm for treatment de-escalation and led to a significant increase in the number of antibiotic-free days at day 14 (5.0 ± 5.1 versus 2.2 ± 3.5) and day 28 (11.5 ± 9.0 versus 7.5 ± 7.6) in comparison with the strategy with non-invasive methods using qualitative cultures. In contrast, the Canadian Critical Care Trial Group reported no impact of distal quantitative samples on the day-28 antibiotic-free days or on survival<sup><a href="#ref-66">66</a></sup>. However, in that study, the research protocol may have facilitated appropriate discontinuation of antibiotics or targeted therapy in the two groups, thus minimizing the differences between them. Cohort studies confirmed the potential advantages of distal quantitative samples in narrowing antimicrobial therapy and limiting antibiotic selection pressure without adverse effects on mortality or length of stay<sup><a href="#ref-69">69</a>–<a href="#ref-71">71</a></sup>. Finally, an observational study in 89 patients with clinically suspected VAP and a negative quantitative bronchoalveolar lavage compared patients with early (within one day) and late antibiotic discontinuation. Early discontinuation was associated with a non-significant decrease in mortality and significantly lower risks of overall superinfections (22.5% versus 43%), respiratory superinfections (10% versus 29%), and superinfections due to MDR pathogens (7.5% versus 36%)<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d24269e851>Considering available literature, recent US guidelines recommend non-invasive sampling with semi-quantitative culture<sup><a href="#ref-7">7</a></sup>, whereas the European guidelines suggest obtaining distal samples with quantitative cultures to improve the accuracy of results<sup><a href="#ref-9">9</a></sup>. Despite this discrepancy, the two guidelines agreed that a bacteriological sample should be performed before any antibiotic treatment in order to reduce antibiotic exposure.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e867>Treatment of ventilator-associated pneumonia</h2><p class="" id=d24269e870>The initial treatment of VAP is based on empirical choices; however, an inappropriate initial antibiotic choice is associated with increased mortality<sup><a href="#ref-21">21</a>,<a href="#ref-73">73</a></sup>. In addition, the recovery of MDR bacteria is clearly associated with an increased risk of inappropriate therapy<sup><a href="#ref-74">74</a></sup>. As discussed earlier, the risk of MDR is conditioned by the local ecological data, previous colonization, and previous antibiotic therapy received by the patients. The increase in the risk of MDR in late-onset infections is challenged by recent studies. Regimens proposed by the North American guidelines are listed in <a href="#T2">Table 2</a><sup><a href="#ref-7">7</a></sup>. An algorithm for an empirical therapy strategy combining guidelines and practical rules is proposed in <a href="#f3">Figure 3</a>.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Empirical treatment of hospital-acquired pneumonia/ventilator-associated pneumonia.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24269e904 class=n-a></a><tbody><a name=d24269e906 class=n-a></a><tr><a name=d24269e908 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d24269e909 class=n-a></a>Not at high risk of mortality<br class=br>and no risk factors<sup><a href="#fn2">a</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d24269e917 class=n-a></a>Not at high risk of mortality but with factors<br class=br>increasing the likelihood of Gram-negative bacteria</td><td colspan=1 rowspan=1 valign=top><a name=d24269e922 class=n-a></a>High risk of mortality or receipt of intravenous<br class=br>antibiotics during the prior 90 days</td></tr><tr><a name=d24269e927 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d24269e928 class=n-a></a>One of the following:<br class=br>Piperacillin-tazobactam 4.5 g<br class=br>IV q6h<br class=br>OR<br class=br>Cefepime 2 g IV q8h<br class=br>Levofloxacin 750 mg IV daily</td><td colspan=1 rowspan=1 valign=top><a name=d24269e941 class=n-a></a>Piperacillin-tazobactam 4.5 g IV q6h<br class=br>OR<br class=br>Cefepime or ceftazidime 2 g IV q8h<br class=br>OR<br class=br>Levofloxacin 750 mg IV daily<br class=br>Ciprofloxacin 400 mg IV q8h<br class=br>OR<br class=br>Imipenem 1g IV q8h<br class=br>Meropenem 1 g IV q6h</td><td colspan=1 rowspan=1 valign=top><a name=d24269e961 class=n-a></a>Piperacillin-tazobactam 4.5 g IV q6h<br class=br>OR<br class=br>Cefepime or ceftazidime 2 g IV q8h<br class=br>OR<br class=br>Levofloxacin 750 mg IV daily<br class=br>Ciprofloxacin 400 mg IV q8h<br class=br>OR<br class=br>Imipenem 1g IV q8h<br class=br>Meropenem 1 g IV q6h<br class=br><br class=br>AND<br class=br><br class=br>Amikacin 25 (30) mg/kg IV daily<br class=br>OR<br class=br>Gentamicin 5–7 mg/kg IV daily<br class=br>OR<br class=br>Tobramycin 5–7 mg/kg IV daily</td></tr><tr><a name=d24269e996 class=n-a></a><td colspan=1 rowspan=1><a name=d24269e998 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d24269e1000 class=n-a></a>Vancomycin 15 mg/kg IV q8–12h with goal to target<br class=br>15–20 mg/mL trough level (consider a loading dose<br class=br>of 25–30 mg/kg × 1 for severe illness)<br class=br><br class=br>OR<br class=br><br class=br>Linezolid 600 mg IV q12h</td><td colspan=1 rowspan=1 valign=top><a name=d24269e1013 class=n-a></a>Vancomycin 15 mg/kg IV q8–12h with goal to<br class=br>target<br class=br>15–20 mg/mL trough level (consider a loading<br class=br>dose of 25–30 mg/kg × 1 for severe illness)<br class=br><br class=br>OR<br class=br><br class=br>Linezolid 600 mg IV q12h</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d24269e1033 class=n-a></a><p id=fn2> Adapted from Infectious Diseases Society of America/American Thoracic Society guidelines<sup><a href="#ref-7">7</a></sup>. <sup>a</sup>Risk factors of multidrug-resistant ventilator-associated pneumonia (VAP) are prior intravenous use within 90 days, septic shock at VAP onset, acute respiratory distress syndrome preceding VAP, five or more days of hospitalization prior to VAP onset, and acute renal replacement therapy prior to VAP onset. IV, intravenous; q, every.</p></div></div></div><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure3.gif"><img alt="6a79512e-456d-41a0-80fe-91b69e7b9d99_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13232/6a79512e-456d-41a0-80fe-91b69e7b9d99_figure3.gif"></a><div class=caption><h3>Figure 3. Proposed strategy for empirical therapy.</h3><p id=d24269e1056>*In areas with a risk of multidrug-resistant and carbapenemase-producing bacteria, the empirical choice should be decided on the basis of local ecology. 3rd GC, third-generation cephalosporin; ARDS, acute respiratory distress syndrome; ATB, antibiotics; GNB, Gram-negative bacteria; MDR, multidrug-resistant; MRSA, methicillin-resistant <i>Staphylococcus aureus</i>; PA, <i>Pseudomonas aeruginosa</i>; PIP/TAZ, piperacillin-tazobactam; R, Resistant; VAP, ventilator-associated pneumonia.</p></div></div><p class="" id=d24269e1069>The challenge for the intensivist is to start an antimicrobial therapy that will be immediately effective while avoiding any overuse of extended-spectrum antimicrobials. New rapid diagnostic tests have been developed but their performances for VAP diagnosis remain to be evaluated<sup><a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>. Rapid nucleic acid amplification or mass spectrometry-based techniques provide rapid identification of targeted microorganisms. Some of these new tests are also able to detect resistance genes. However, the presence of genes detected by these techniques does not mean that the pathogens are alive or dead, nor does it provide information regarding phenotypic antimicrobial susceptibility. Rapid culture with semi-automated rapid antibiotic susceptibility tests are also in development. Fluorescence <i>in situ</i> hybridization-based microscopy identification and antibiotic susceptibility test (ID/AST) systems can evaluate antibiotic susceptibility from respiratory secretions on a previously defined panel of pathogens. A recent pilot study reported promising results: the technique was able to detect pathogens in bronchoalveolar lavage after 5 ± 7 hours of culture and 5 hours of analysis, and sensitivity and specificity were 100% and 97%, respectively<sup><a href="#ref-77">77</a></sup>. Technical developments with a better selection and quantification of pathogens and resistance patterns are warranted.</p><p class="" id=d24269e1087>Beta-lactams remain a cornerstone antibiotic for the treatment of VAP. Critical care patients exhibit high clearance and distribution volume, which contribute to low blood levels of antimicrobials<sup><a href="#ref-78">78</a></sup>. Therefore, the doses that should be used to treat the most severe patients are frequently higher than the ones approved by regulatory agencies<sup><a href="#ref-79">79</a></sup>. For β-lactams, the best results seem to be associated with β-lactam plasma levels up to four times the minimal inhibitory concentration (MIC) of the involved pathogen and during 100% of the interval between each dose<sup><a href="#ref-80">80</a></sup>. For these agents, a loading dose followed by a continuous infusion may be a relevant method of administration to increase the antibiotic concentration in the blood and the lung lining fluid with a lower risk of neurological<sup><a href="#ref-81">81</a></sup> or renal<sup><a href="#ref-82">82</a></sup> toxicity. It is of special importance when bacteria are not fully susceptible or when MICs are high, as for <i>P. aeruginosa</i> and MDR Gram-negative bacteria<sup><a href="#ref-83">83</a></sup>.</p><p class="" id=d24269e1118>Combination therapy with aminoglycosides increases the likelihood to immediately achieve an adequate therapy, especially for infection due to MDR Gram-negative bacteria<sup><a href="#ref-84">84</a></sup>. It is associated with an improved prognosis in the most severe patients<sup><a href="#ref-85">85</a></sup>. A dose as high as 25 mg/kg of amikacin is required to reach the optimal 60 mg/L peak concentration, even in the case of renal failure. Indeed, the distribution volume of aminoglycosides is not affected by renal dysfunction<sup><a href="#ref-86">86</a></sup>. However, renal impairment, present in almost 30% of ICU patients, will lead to prolonged intervals between doses, reducing the actual number of peak levels, thus possibly affecting the treatment efficiency.</p><p class="" id=d24269e1133>Indeed, controversies still exist about advantages and disadvantages of aminoglycosides. Ong <i>et al</i>. compared empirical therapy of septic shock with or without gentamicin in two Dutch ICUs<sup><a href="#ref-87">87</a></sup>. One of the ICUs preferentially used aminoglycosides, whereas the other preferentially avoided them. After careful adjustment on patients’ characteristics, they found that gentamicin is an independent predictor of renal failure without affecting mortality. The main limitations of this study include (1) the absence of random allocation, (2) the absence of control on center effect, (3) the setting in two ICUs where the rate of MDR Gram-negative organisms is very low with a minimal risk of inadequate therapy, and (4) the absence of therapeutic drug monitoring for gentamicin. Nevertheless, the study by Ong <i>et al</i>.<sup><a href="#ref-87">87</a></sup> emphasizes the importance of new well-conducted studies comparing antimicrobial therapy with or without aminoglycosides, given with careful therapeutic drug monitoring, for the most severe ICU patients.</p><p class="" id=d24269e1150>Combination therapy with fluoroquinolones was associated with a decrease in the number of days alive without relapse or reinfection in a cohort of patients with VAP due to <i>P. aeruginosa</i> or <i>Enterobacteriaceae</i> and without any prior treatment with fluoroquinolones<sup><a href="#ref-88">88</a></sup>. However, the fluoroquinolones are inconstantly active against MDR Gram-negative bacteria and their use is associated with an important risk of emergence of MDR bacteria in the lung and gut microbiota<sup><a href="#ref-89">89</a></sup>.</p><p class="" id=d24269e1167>Concerning extended-spectrum β-lactamase-producing <i>Enterobacteriaceae</i> (ESBL-PE), carbapenems remain the first-line agents despite leading to the risk of emergence and spread of carbapenemase-producing <i>Enterobacteriaceae</i><sup><a href="#ref-90">90</a></sup>. Other options such as piperacillin/tazobactam or a high dose of third-generation cephalosporins administered by continuous infusion could be considered, especially as step-down therapy for ESBL-PE with low MICs<sup><a href="#ref-30">30</a></sup>. New compounds such as ceftolozane/tazobactam and ceftazidime/avibactam have recently been released; however, against HAP/VAP, only the latter was non-inferior to meropenem in a recent randomized trial (REPROVE NCT01808092; results available on ClinicalTrials.gov, not yet published). Temocillin, a ticarcillin derivative that resists ESBL, can be used but only as a step-down therapy for pathogens with MICs below 8 mg/L<sup><a href="#ref-91">91</a></sup>. For carbapenem-resistant Gram-negative bacteria, colistin is a cornerstone of the treatment, although ceftazidime/avibactam association might be effective. A new association of meropenem and vaborbactam (M-V), recently approved for severe urinary tract infections in the US, has been compared with best available therapy (BAT) in severe infection presumably due to carbapenemase R <i>Enterobacteriaceae</i>, including nosocomial pneumonia (TANGO-2 NCT 02168946). The study was presented at the IDWeek convention (in San Diego, CA, in October 2017; abstract 1867) and enrolled 43 patients (more than 80% with <i>Klebsiella pneumoniae carbapenemase</i>). It has been stopped prematurely for significant superiority in terms of clinical failure, nephrotoxicity, and non-significant improvement of day-28 mortality of patients with HAP/VAP (M-V 4/16 versus BAT 4/9). Further studies are awaited to confirm these encouraging results and make formal recommendations on its use. An intravenous colistin regimen should be considered with a loading dose of 9 MU and with caution regarding its potential nephrotoxicity<sup><a href="#ref-92">92</a></sup>.</p><p class="" id=d24269e1198>Inhaled antimicrobial therapy may be considered, as this route of administration enables very high concentrations of antimicrobials to be locally delivered<sup><a href="#ref-93">93</a>,<a href="#ref-94">94</a></sup>. However, there are no solutions specifically formulated for inhalation, and a limited number of devices are designed for the nebulization of antibiotics<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. Of note, despite the possible advantages in terms of microbiological eradication and emergence of resistance<sup><a href="#ref-97">97</a></sup>, no impact on patient prognosis has been demonstrated<sup><a href="#ref-94">94</a>,<a href="#ref-97">97</a>–<a href="#ref-99">99</a></sup>.</p><p class="" id=d24269e1230>In units with rates of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) around 10–20%, include vancomycin or linezolid in the empirical therapy<sup><a href="#ref-7">7</a></sup>. When the MIC to vancomycin is higher than 1.5 mg/L, the mortality of MRSA pneumonia is higher<sup><a href="#ref-100">100</a></sup>. Moreover, it is very difficult to reach pharmacokinetic targets using vancomycin<sup><a href="#ref-101">101</a></sup> without any increase in renal toxicity. Consequently, linezolid should be preferred, particularly in patients with renal impairment or if the MRSA MIC to vancomycin is over 1.5 mg/L<sup><a href="#ref-102">102</a></sup>.</p><p class="" id=d24269e1252>An 8-day antibiotic course appears safe in VAP. This duration can be shortened when a procalcitonin-guided algorithm is used<sup><a href="#ref-103">103</a></sup> or when ventilator settings (PEEP ≤5 cm H<sub>2</sub>O and FiO<sub>2</sub> ≤40%) are stable for 48 hours after antibiotic initiation<sup><a href="#ref-104">104</a></sup>. As procalcitonin levels above 1.5 ng/mL after three days of treatment seemed strongly associated with a poor outcome<sup><a href="#ref-105">105</a></sup>, re-evaluation of the accuracy of diagnosis and a search for drainable collections (for example, lung abscess or empyema) and revision of therapeutic antimicrobial regimens should be promptly revisited when procalcitonin levels remain high. However, definite data are lacking where <i>Pseudomonas</i>, <i>Acinetobacter</i>, <i>Stenotrophomonas</i>, and MRSA are concerned.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24269e1286>Abbreviations</h2><p class="" id=d24269e1289>BAT, best available therapy; CDC, Centers for Disease Control and Prevention; ESBL-PE, extended-spectrum beta-lactamase-producing <i>Enterobacteriaceae</i>; FiO<sub>2</sub>, fraction of inspired oxygen; HAP, hospital-acquired pneumonia; ICU, intensive care unit; IVAC, infection-related ventilator-associated complication; MDR, multidrug-resistant; MIC, minimal inhibitory concentration; MRSA, methicillin-resistant <i>Staphylococcus aureus</i>; M-V, meropenem and vaborbactam; OR, odds ratio; PEEP, positive end expiratory pressure; SDD, selective digestive decontamination; SOD, selective oropharyngeal decontamination; VAC, ventilator-associated complication; VAE, ventilator-associated event; VAP, ventilator-associated pneumonia; VAT, ventilator-associated tracheobronchitis.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d24269e1 class=n-a></a><h2 class=main-title id=d24609>Competing interests</h2><p class=metadata-entry><a name=d24269e151 class=n-a></a><p id=d24269e152> J-FT gave lectures for Merck, Pfizer, and Gilead on antimicrobial therapy and participated in scientific boards of Paratek, Bayer, Merck, and 3M. The other authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d24269e1 class=n-a></a><h2 class=main-title id=d24611>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d24269e1305 class=n-a></a><h2 class=main-title id=d24269e1307>Acknowledgments</h2><p class="" id=d24269e1310>The authors thank Celine Feger (EMIBiotech) for her editorial assistance.</p></div><div class=back-section><a name=d24269e1314 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d24944>References</h2><div class="section ref-list"><a name=d24269e1314 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d24269e1321 class=n-a></a>American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. <i>Am J Respir Crit Care Med.</i> 2005; <b>171</b>(4): 388–416. <a target=xrefwindow id=d24269e1329 href="http://www.ncbi.nlm.nih.gov/pubmed/15699079">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1332 href="http://dx.doi.org/10.1164/rccm.200405-644ST">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d24269e1341 class=n-a></a>Chastre J, Fagon JY: Ventilator-associated pneumonia. <i>Am J Respir Crit Care Med.</i> 2002; <b>165</b>(7): 867–903. <a target=xrefwindow id=d24269e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/11934711">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1352 href="http://dx.doi.org/10.1164/ajrccm.165.7.2105078">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d24269e1361 class=n-a></a>Craven DE, Hudcova J, Lei Y: Diagnosis of ventilator-associated respiratory infections (VARI): microbiologic clues for tracheobronchitis (VAT) and pneumonia (VAP). <i>Clin Chest Med.</i> 2011; <b>32</b>(3): 547–57. <a target=xrefwindow id=d24269e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/21867822">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1372 href="http://dx.doi.org/10.1016/j.ccm.2011.06.001">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d24269e1381 class=n-a></a>Martin-Loeches I, Papiol E, Almansa R, <i> et al.</i>: Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: a pilot study. <i>Med Intensiva.</i> 2012; <b>36</b>(4): 257–63. <a target=xrefwindow id=d24269e1392 href="http://www.ncbi.nlm.nih.gov/pubmed/22301068">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1395 href="http://dx.doi.org/10.1016/j.medin.2011.10.009">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d24269e1404 class=n-a></a>Rello J, Riera J, Serrano R: What's new in ventilator-associated pneumonia? <i>Intensive Care Med.</i> 2015; <b>41</b>(11): 1954–6. <a target=xrefwindow id=d24269e1412 href="http://www.ncbi.nlm.nih.gov/pubmed/26077094">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1415 href="http://dx.doi.org/10.1007/s00134-015-3909-8">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d24269e1425 class=n-a></a>Magill SS, Klompas M, Balk R, <i> et al.</i>: Developing a new, national approach to surveillance for ventilator-associated events: executive summary. <i>Clin Infect Dis.</i> 2013; <b>57</b>(12): 1742–6. <a target=xrefwindow id=d24269e1436 href="http://www.ncbi.nlm.nih.gov/pubmed/24280662">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1439 href="http://dx.doi.org/10.1093/cid/cit577">Publisher Full Text </a> | <a target=xrefwindow id=d24269e1443 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3840402">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726507459"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e1452 class=n-a></a>Kalil AC, Metersky ML, Klompas M, <i> et al.</i>: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. <i>Clin Infect Dis.</i> 2016; <b>63</b>(5): e61–e111. <a target=xrefwindow id=d24269e1463 href="http://www.ncbi.nlm.nih.gov/pubmed/27418577">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1466 href="http://dx.doi.org/10.1093/cid/ciw353">Publisher Full Text </a> | <a target=xrefwindow id=d24269e1470 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4981759">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726507459">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d24269e1483 class=n-a></a>Timsit JF, de Kraker MEA, Sommer H, <i> et al.</i>: Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net. <i>Intensive Care Med.</i> 2017; <b>43</b>(7): 1002–1012. <a target=xrefwindow id=d24269e1494 href="http://www.ncbi.nlm.nih.gov/pubmed/28466147">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1497 href="http://dx.doi.org/10.1007/s00134-017-4802-4">Publisher Full Text </a> | <a target=xrefwindow id=d24269e1501 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5487537">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d24269e1510 class=n-a></a>Torres A, Niederman MS, Chastre J, <i> et al.</i>: International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). <i>Eur Respir J.</i> 2017; <b>50</b>(3): pii: 1700582. <a target=xrefwindow id=d24269e1521 href="http://www.ncbi.nlm.nih.gov/pubmed/28890434">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1524 href="http://dx.doi.org/10.1183/13993003.00582-2017">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d24269e1533 class=n-a></a>Barbier F, Andremont A, Wolff M, <i> et al.</i>: Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. <i>Curr Opin Pulm Med.</i> 2013; <b>19</b>(3): 216–28. <a target=xrefwindow id=d24269e1544 href="http://www.ncbi.nlm.nih.gov/pubmed/23524477">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1547 href="http://dx.doi.org/10.1097/MCP.0b013e32835f27be">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d24269e1556 class=n-a></a>Rosenthal VD, Bijie H, Maki DG, <i> et al.</i>: International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009. <i>Am J Infect Control.</i> 2012; <b>40</b>(5): 396–407. <a target=xrefwindow id=d24269e1567 href="http://www.ncbi.nlm.nih.gov/pubmed/21908073">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1570 href="http://dx.doi.org/10.1016/j.ajic.2011.05.020">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d24269e1580 class=n-a></a>Bouadma L, Sonneville R, Garrouste-Orgeas M, <i> et al.</i>: Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia. <i>Crit Care Med.</i> 2015; <b>43</b>(9): 1798–806. <a target=xrefwindow id=d24269e1591 href="http://www.ncbi.nlm.nih.gov/pubmed/25978340">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1594 href="http://dx.doi.org/10.1097/CCM.0000000000001091">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d24269e1603 class=n-a></a>Warren DK, Shukla SJ, Olsen MA, <i> et al.</i>: Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. <i>Crit Care Med.</i> 2003; <b>31</b>(5): 1312–7. <a target=xrefwindow id=d24269e1614 href="http://www.ncbi.nlm.nih.gov/pubmed/12771596">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1617 href="http://dx.doi.org/10.1097/01.CCM.0000063087.93157.06">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d24269e1626 class=n-a></a>Klompas M: Does this patient have ventilator-associated pneumonia? <i>JAMA.</i> 2007; <b>297</b>(14): 1583–93. <a target=xrefwindow id=d24269e1634 href="http://www.ncbi.nlm.nih.gov/pubmed/17426278">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1637 href="http://dx.doi.org/10.1001/jama.297.14.1583">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d24269e1646 class=n-a></a>Safdar N, Dezfulian C, Collard HR, <i> et al.</i>: Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. <i>Crit Care Med.</i> 2005; <b>33</b>(10): 2184–93. <a target=xrefwindow id=d24269e1657 href="http://www.ncbi.nlm.nih.gov/pubmed/16215368">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1660 href="http://dx.doi.org/10.1097/01.CCM.0000181731.53912.D9">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d24269e1669 class=n-a></a>Timsit J, Zahar J, Chevret S: Attributable mortality of ventilator-associated pneumonia. <i>Curr Opin Crit Care.</i> 2011; <b>17</b>(5): 464–71. <a target=xrefwindow id=d24269e1677 href="http://www.ncbi.nlm.nih.gov/pubmed/21844801">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1680 href="http://dx.doi.org/10.1097/MCC.0b013e32834a5ae9">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d24269e1689 class=n-a></a>Melsen WG, Rovers MM, Groenwold RHH, <i> et al.</i>: Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. <i>Lancet Infect Dis.</i> 2013; <b>13</b>(8): 665–71. <a target=xrefwindow id=d24269e1700 href="http://www.ncbi.nlm.nih.gov/pubmed/23622939">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1703 href="http://dx.doi.org/10.1016/S1473-3099(13)70081-1">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d24269e1713 class=n-a></a>Nguile-Makao M, Zahar JR, Français A, <i> et al.</i>: Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. <i>Intensive Care Med.</i> 2010; <b>36</b>(5): 781–9. <a target=xrefwindow id=d24269e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/20232046">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1727 href="http://dx.doi.org/10.1007/s00134-010-1824-6">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13387959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e1736 class=n-a></a>Bekaert M, Timsit JF, Vansteelandt S, <i> et al.</i>: Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. <i>Am J Respir Crit Care Med.</i> 2011; <b>184</b>(10): 1133–9. <a target=xrefwindow id=d24269e1747 href="http://www.ncbi.nlm.nih.gov/pubmed/21852541">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1750 href="http://dx.doi.org/10.1164/rccm.201105-0867OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13387959">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d24269e1763 class=n-a></a>Ibrahim EH, Ward S, Sherman G, <i> et al.</i>: A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. <i>Chest.</i> 2000; <b>117</b>(5): 1434–42. <a target=xrefwindow id=d24269e1774 href="http://www.ncbi.nlm.nih.gov/pubmed/10807834">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1777 href="http://dx.doi.org/10.1378/chest.117.5.1434">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d24269e1786 class=n-a></a>Moine P, Timsit J, De Lassence A, <i> et al.</i>: Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. <i>Intensive Care Med.</i> 2002; <b>28</b>(2): 154–63. <a target=xrefwindow id=d24269e1797 href="http://www.ncbi.nlm.nih.gov/pubmed/11907658">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1800 href="http://dx.doi.org/10.1007/s00134-001-1172-7">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d24269e1809 class=n-a></a>Vallés J, Pobo A, García-Esquirol O, <i> et al.</i>: Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. <i>Intensive Care Med.</i> 2007; <b>33</b>(8): 1363–8. <a target=xrefwindow id=d24269e1820 href="http://www.ncbi.nlm.nih.gov/pubmed/17558495">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1823 href="http://dx.doi.org/10.1007/s00134-007-0721-0">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d24269e1832 class=n-a></a>Park DR: The microbiology of ventilator-associated pneumonia. <i>Respir Care.</i> 2005; <b>50</b>(6): 742–63; discussion 763–5. <a target=xrefwindow id=d24269e1840 href="http://www.ncbi.nlm.nih.gov/pubmed/15913466">PubMed Abstract </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d24269e1850 class=n-a></a>Trouillet JL, Chastre J, Vuagnat A, <i> et al.</i>: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. <i>Am J Respir Crit Care Med.</i> 1998; <b>157</b>(2): 531–9. <a target=xrefwindow id=d24269e1861 href="http://www.ncbi.nlm.nih.gov/pubmed/9476869">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1864 href="http://dx.doi.org/10.1164/ajrccm.157.2.9705064">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d24269e1873 class=n-a></a>Ferrer M, Liapikou A, Valencia M, <i> et al.</i>: Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. <i>Clin Infect Dis.</i> 2010; <b>50</b>(7): 945–52. <a target=xrefwindow id=d24269e1884 href="http://www.ncbi.nlm.nih.gov/pubmed/20175690">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1887 href="http://dx.doi.org/10.1086/651075">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d24269e1896 class=n-a></a>Martin-Loeches I, Deja M, Koulenti D, <i> et al.</i>: Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. <i>Intensive Care Med.</i> 2013; <b>39</b>(4): 672–81. <a target=xrefwindow id=d24269e1907 href="http://www.ncbi.nlm.nih.gov/pubmed/23358539">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1910 href="http://dx.doi.org/10.1007/s00134-012-2808-5">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725854250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e1919 class=n-a></a>Martin-Loeches I, Povoa P, Rodríguez A, <i> et al.</i>: Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. <i>Lancet Respir Med.</i> 2015; <b>3</b>(11): 859–68. <a target=xrefwindow id=d24269e1930 href="http://www.ncbi.nlm.nih.gov/pubmed/26472037">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1933 href="http://dx.doi.org/10.1016/S2213-2600(15)00326-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725854250">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d24269e1946 class=n-a></a>Gastmeier P, Sohr D, Geffers C, <i> et al.</i>: Early- and late-onset pneumonia: is this still a useful classification? <i>Antimicrob Agents Chemother.</i> 2009; <b>53</b>(7): 2714–8. <a target=xrefwindow id=d24269e1957 href="http://www.ncbi.nlm.nih.gov/pubmed/19364852">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1960 href="http://dx.doi.org/10.1128/AAC.01070-08">Publisher Full Text </a> | <a target=xrefwindow id=d24269e1964 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2704703">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d24269e1973 class=n-a></a>Restrepo MI, Peterson J, Fernandez JF, <i> et al.</i>: Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. <i>Respir Care.</i> 2013; <b>58</b>(7): 1220–5. <a target=xrefwindow id=d24269e1984 href="http://www.ncbi.nlm.nih.gov/pubmed/23307825">PubMed Abstract </a> | <a target=xrefwindow id=d24269e1987 href="http://dx.doi.org/10.4187/respcare.02173">Publisher Full Text </a> | <a target=xrefwindow id=d24269e1991 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4066648">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d24269e2001 class=n-a></a>Timsit JF, Pilmis B, Zahar JR: How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae?</i> <i>Semin Respir Crit Care Med.</i> 2017; <b>38</b>(3): 287–300. <a target=xrefwindow id=d24269e2012 href="http://www.ncbi.nlm.nih.gov/pubmed/28578553">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2015 href="http://dx.doi.org/10.1055/s-0037-1603112">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6282956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2024 class=n-a></a>Lacherade JC, de Jonghe B, Guezennec P, <i> et al.</i>: Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. <i>Am J Respir Crit Care Med.</i> 2010; <b>182</b>(7): 910–7. <a target=xrefwindow id=d24269e2035 href="http://www.ncbi.nlm.nih.gov/pubmed/20522796">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2038 href="http://dx.doi.org/10.1164/rccm.200906-0838OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6282956">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d24269e2051 class=n-a></a>Bouadma L, Wolff M, Lucet JC: Ventilator-associated pneumonia and its prevention. <i>Curr Opin Infect Dis.</i> 2012; <b>25</b>(4): 395–404. <a target=xrefwindow id=d24269e2059 href="http://www.ncbi.nlm.nih.gov/pubmed/22744316">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2062 href="http://dx.doi.org/10.1097/QCO.0b013e328355a835">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d24269e2071 class=n-a></a>Adair CG, Gorman SP, Feron BM, <i> et al.</i>: Implications of endotracheal tube biofilm for ventilator-associated pneumonia. <i>Intensive Care Med.</i> 1999; <b>25</b>(10): 1072–6. <a target=xrefwindow id=d24269e2082 href="http://www.ncbi.nlm.nih.gov/pubmed/10551961">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2085 href="http://dx.doi.org/10.1007/s001340051014">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1060727"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2094 class=n-a></a>Pronovost P, Needham D, Berenholtz S, <i> et al.</i>: An intervention to decrease catheter-related bloodstream infections in the ICU. <i>N Engl J Med.</i> 2006; <b>355</b>(26): 2725–32. <a target=xrefwindow id=d24269e2105 href="http://www.ncbi.nlm.nih.gov/pubmed/17192537">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2108 href="http://dx.doi.org/10.1056/NEJMoa061115">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1060727">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d24269e2121 class=n-a></a>Reignier J, Darmon M, Sonneville R, <i> et al.</i>: Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study. <i>Intensive Care Med.</i> 2015; <b>41</b>(5): 875–86. <a target=xrefwindow id=d24269e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/25792207">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2135 href="http://dx.doi.org/10.1007/s00134-015-3730-4">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d24269e2145 class=n-a></a>Fitch ZW, Whitman GJ: Incidence, risk, and prevention of ventilator-associated pneumonia in adult cardiac surgical patients: a systematic review. <i>J Card Surg.</i> 2014; <b>29</b>(2): 196–203. <a target=xrefwindow id=d24269e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/24304223">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2156 href="http://dx.doi.org/10.1111/jocs.12260">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718042733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2165 class=n-a></a>Schwebel C, Clec'h C, Magne S, <i> et al.</i>: Safety of intrahospital transport in ventilated critically ill patients: a multicenter cohort study*. <i>Crit Care Med.</i> 2013; <b>41</b>(8): 1919–28. <a target=xrefwindow id=d24269e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/23863225">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2179 href="http://dx.doi.org/10.1097/CCM.0b013e31828a3bbd">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718042733">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d24269e2192 class=n-a></a>Bornstain C, Azoulay E, De Lassence A, <i> et al.</i>: Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia. <i>Clin Infect Dis.</i> 2004; <b>38</b>(10): 1401–8. <a target=xrefwindow id=d24269e2203 href="http://www.ncbi.nlm.nih.gov/pubmed/15156478">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2206 href="http://dx.doi.org/10.1086/386321">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d24269e2215 class=n-a></a>Klompas M, Branson R, Eichenwald EC, <i> et al.</i>: Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. <i>Infect Control Hosp Epidemiol.</i> 2014; <b>35 Suppl 2</b>: S133–54. <a target=xrefwindow id=d24269e2226 href="http://www.ncbi.nlm.nih.gov/pubmed/25376073">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2229 href="http://dx.doi.org/10.1017/S0899823X00193894">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d24269e2238 class=n-a></a>Huang H, Li Y, Ariani F, <i> et al.</i>: Timing of tracheostomy in critically ill patients: a meta-analysis. <i>PLoS One.</i> 2014; <b>9</b>(3): e92981. <a target=xrefwindow id=d24269e2249 href="http://www.ncbi.nlm.nih.gov/pubmed/24667875">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2252 href="http://dx.doi.org/10.1371/journal.pone.0092981">Publisher Full Text </a> | <a target=xrefwindow id=d24269e2256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3965497">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726884845"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2265 class=n-a></a>Meng L, Wang C, Li J, <i> et al.</i>: Early vs late tracheostomy in critically ill patients: a systematic review and meta-analysis. <i>Clin Respir J.</i> 2016; <b>10</b>(6): 684–92. <a target=xrefwindow id=d24269e2276 href="http://www.ncbi.nlm.nih.gov/pubmed/25763477">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2279 href="http://dx.doi.org/10.1111/crj.12286">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726884845">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725287865"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2293 class=n-a></a>Szakmany T, Russell P, Wilkes AR, <i> et al.</i>: Effect of early tracheostomy on resource utilization and clinical outcomes in critically ill patients: meta-analysis of randomized controlled trials. <i>Br J Anaesth.</i> 2015; <b>114</b>(3): 396–405. <a target=xrefwindow id=d24269e2304 href="http://www.ncbi.nlm.nih.gov/pubmed/25534400">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2307 href="http://dx.doi.org/10.1093/bja/aeu440">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725287865">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d24269e2320 class=n-a></a>Clec'h C, Alberti C, Vincent F, <i> et al.</i>: Tracheostomy does not improve the outcome of patients requiring prolonged mechanical ventilation: a propensity analysis. <i>Crit Care Med.</i> 2007; <b>35</b>(1): 132–8. <a target=xrefwindow id=d24269e2331 href="http://www.ncbi.nlm.nih.gov/pubmed/17133180">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2334 href="http://dx.doi.org/10.1097/01.CCM.0000251134.96055.A6">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d24269e2343 class=n-a></a>Rello J, Lode H, Cornaglia G, <i> et al.</i>: A European care bundle for prevention of ventilator-associated pneumonia. <i>Intensive Care Med.</i> 2010; <b>36</b>(5): 773–80. <a target=xrefwindow id=d24269e2354 href="http://www.ncbi.nlm.nih.gov/pubmed/20237759">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2357 href="http://dx.doi.org/10.1007/s00134-010-1841-5">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/7668956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2366 class=n-a></a>Bouadma L, Deslandes E, Lolom I, <i> et al.</i>: Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. <i>Clin Infect Dis.</i> 2010; <b>51</b>(10): 1115–22. <a target=xrefwindow id=d24269e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/20936973">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2380 href="http://dx.doi.org/10.1086/656737">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/7668956">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718106773"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2393 class=n-a></a>Muscedere J, Sinuff T, Heyland DK, <i> et al.</i>: The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. <i>Chest.</i> 2013; <b>144</b>(5): 1453–60. <a target=xrefwindow id=d24269e2404 href="http://www.ncbi.nlm.nih.gov/pubmed/24030318">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2407 href="http://dx.doi.org/10.1378/chest.13-0853">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718106773">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13396959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2420 class=n-a></a>Morris AC, Hay AW, Swann DG, <i> et al.</i>: Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. <i>Crit Care Med.</i> 2011; <b>39</b>(10): 2218–24. <a target=xrefwindow id=d24269e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/21666444">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2434 href="http://dx.doi.org/10.1097/CCM.0b013e3182227d52">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13396959">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d24269e2448 class=n-a></a>Speck K, Rawat N, Weiner NC, <i> et al.</i>: A systematic approach for developing a ventilator-associated pneumonia prevention bundle. <i>Am J Infect Control.</i> 2016; <b>44</b>(6): 652–6. <a target=xrefwindow id=d24269e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/26874407">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2462 href="http://dx.doi.org/10.1016/j.ajic.2015.12.020">Publisher Full Text </a> | <a target=xrefwindow id=d24269e2466 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4887312">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718888837"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2475 class=n-a></a>Roquilly A, Marret E, Abraham E, <i> et al.</i>: Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. <i>Clin Infect Dis.</i> 2015; <b>60</b>(1): 64–75. <a target=xrefwindow id=d24269e2486 href="http://www.ncbi.nlm.nih.gov/pubmed/25252684">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2489 href="http://dx.doi.org/10.1093/cid/ciu740">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718888837">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732162898"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2502 class=n-a></a>Metersky ML, Wang Y, Klompas M, <i> et al.</i>: Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013. <i>JAMA.</i> 2016; <b>316</b>(22): 2427–9. <a target=xrefwindow id=d24269e2513 href="http://www.ncbi.nlm.nih.gov/pubmed/27835709">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2516 href="http://dx.doi.org/10.1001/jama.2016.16226">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732162898">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1145249"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2529 class=n-a></a>de Smet AM, Kluytmans JA, Cooper BS, <i> et al.</i>: Decontamination of the digestive tract and oropharynx in ICU patients. <i>N Engl J Med.</i> 2009; <b>360</b>(1): 20–31. <a target=xrefwindow id=d24269e2540 href="http://www.ncbi.nlm.nih.gov/pubmed/19118302">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2543 href="http://dx.doi.org/10.1056/NEJMoa0800394">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1145249">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d24269e2556 class=n-a></a>Oostdijk EAN, Kesecioglu J, Schultz MJ, <i> et al.</i>: Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. <i>JAMA.</i> 2014; <b>312</b>(14): 1429–37. <a target=xrefwindow id=d24269e2567 href="http://www.ncbi.nlm.nih.gov/pubmed/25271544">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2570 href="http://dx.doi.org/10.1001/jama.2014.7247">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732163209"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2579 class=n-a></a>Klompas M: Oropharyngeal Decontamination with Antiseptics to Prevent Ventilator-Associated Pneumonia: Rethinking the Benefits of Chlorhexidine. <i>Semin Respir Crit Care Med.</i> 2017; <b>38</b>(3): 381–90. <a target=xrefwindow id=d24269e2587 href="http://www.ncbi.nlm.nih.gov/pubmed/28578560">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2590 href="http://dx.doi.org/10.1055/s-0037-1602584">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732163209">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d24269e2604 class=n-a></a>Rello J, Lorente C, Bodí M, <i> et al.</i>: Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. <i>Chest.</i> 2002; <b>122</b>(2): 656–61. <a target=xrefwindow id=d24269e2615 href="http://www.ncbi.nlm.nih.gov/pubmed/12171847">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2618 href="http://dx.doi.org/10.1378/chest.122.2.656">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d24269e2627 class=n-a></a>Ricart M, Lorente C, Diaz E, <i> et al.</i>: Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. <i>Crit Care Med.</i> 2003; <b>31</b>(11): 2693–6. <a target=xrefwindow id=d24269e2638 href="http://www.ncbi.nlm.nih.gov/pubmed/14605543">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2641 href="http://dx.doi.org/10.1097/01.CCM.0000094226.05094.AA">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d24269e2650 class=n-a></a>Pittet D: The Lowbury lecture: behaviour in infection control. <i>J Hosp Infect.</i> 2004; <b>58</b>(1): 1–13. <a target=xrefwindow id=d24269e2658 href="http://www.ncbi.nlm.nih.gov/pubmed/15350707">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2661 href="http://dx.doi.org/10.1016/j.jhin.2004.06.002">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d24269e2670 class=n-a></a>Bouadma L, Mourvillier B, Deiler V, <i> et al.</i>: Changes in knowledge, beliefs, and perceptions throughout a multifaceted behavioral program aimed at preventing ventilator-associated pneumonia. <i>Intensive Care Med.</i> 2010; <b>36</b>(8): 1341–7. <a target=xrefwindow id=d24269e2681 href="http://www.ncbi.nlm.nih.gov/pubmed/20431867">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2684 href="http://dx.doi.org/10.1007/s00134-010-1890-9">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725249181"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2693 class=n-a></a>Nair GB, Niederman MS: Ventilator-associated pneumonia: present understanding and ongoing debates. <i>Intensive Care Med.</i> 2015; <b>41</b>(1): 34–48. <a target=xrefwindow id=d24269e2701 href="http://www.ncbi.nlm.nih.gov/pubmed/25427866">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2704 href="http://dx.doi.org/10.1007/s00134-014-3564-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725249181">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d24269e2717 class=n-a></a>Tejerina E, Esteban A, Fernández-Segoviano P, <i> et al.</i>: Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings. <i>J Crit Care.</i> 2010; <b>25</b>(1): 62–8. <a target=xrefwindow id=d24269e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/19592209">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2731 href="http://dx.doi.org/10.1016/j.jcrc.2009.05.008">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d24269e2741 class=n-a></a>Dudeck MA, Horan TC, Peterson KD, <i> et al.</i>: National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. <i>Am J Infect Control.</i> 2011; <b>39</b>(10): 798–816. <a target=xrefwindow id=d24269e2752 href="http://www.ncbi.nlm.nih.gov/pubmed/22133532">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2755 href="http://dx.doi.org/10.1016/j.ajic.2011.10.001">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d24269e2764 class=n-a></a>Magill SS, Klompas M, Balk R, <i> et al.</i>: Developing a new, national approach to surveillance for ventilator-associated events*. <i>Crit Care Med.</i> 2013; <b>41</b>(11): 2467–75. <a target=xrefwindow id=d24269e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/24162674">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2778 href="http://dx.doi.org/10.1097/CCM.0b013e3182a262db">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723871593"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2787 class=n-a></a>Ego A, Preiser JC, Vincent JL: Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. <i>Chest.</i> 2015; <b>147</b>(2): 347–55. <a target=xrefwindow id=d24269e2795 href="http://www.ncbi.nlm.nih.gov/pubmed/25340476">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2798 href="http://dx.doi.org/10.1378/chest.14-0610">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723871593">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d24269e2811 class=n-a></a>Timsit JF, Misset B, Francoual S, <i> et al.</i>: Is protected specimen brush a reproducible method to diagnose ICU-acquired pneumonia? <i>Chest.</i> 1993; <b>104</b>(1): 104–8. <a target=xrefwindow id=d24269e2822 href="http://www.ncbi.nlm.nih.gov/pubmed/8325050">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2825 href="http://dx.doi.org/10.1378/chest.104.1.104">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d24269e2834 class=n-a></a>Gerbeaux P, Ledoray V, Boussuges A, <i> et al.</i>: Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage. <i>Am J Respir Crit Care Med.</i> 1998; <b>157</b>(1): 76–80. <a target=xrefwindow id=d24269e2845 href="http://www.ncbi.nlm.nih.gov/pubmed/9445281">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2848 href="http://dx.doi.org/10.1164/ajrccm.157.1.9604070">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d24269e2857 class=n-a></a>de Lassence A, Joly-Guillou ML, Salah A, <i> et al.</i>: Accuracy of delayed (24 hours) processing of bronchoalveolar lavage for diagnosing bacterial pneumonia. <i>Crit Care Med.</i> 2004; <b>32</b>(3): 680–5. <a target=xrefwindow id=d24269e2868 href="http://www.ncbi.nlm.nih.gov/pubmed/15090947">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2871 href="http://dx.doi.org/10.1097/01.CCM.0000114813.85853.EA">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1058709"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e2881 class=n-a></a>Canadian Critical Care Trials Group: A randomized trial of diagnostic techniques for ventilator-associated pneumonia. <i>N Engl J Med.</i> 2006; <b>355</b>(25): 2619–30. <a target=xrefwindow id=d24269e2889 href="http://www.ncbi.nlm.nih.gov/pubmed/17182987">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2892 href="http://dx.doi.org/10.1056/NEJMoa052904">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1058709">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d24269e2905 class=n-a></a>Fagon JY, Chastre J, Wolff M, <i> et al.</i>: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. <i>Ann Intern Med.</i> 2000; <b>132</b>(8): 621–30. <a target=xrefwindow id=d24269e2916 href="http://www.ncbi.nlm.nih.gov/pubmed/10766680">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2919 href="http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00004">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d24269e2928 class=n-a></a>Solé Violán J, Fernández JA, Benítez AB, <i> et al.</i>: Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. <i>Crit Care Med.</i> 2000; <b>28</b>(8): 2737–41. <a target=xrefwindow id=d24269e2939 href="http://www.ncbi.nlm.nih.gov/pubmed/10966244">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2942 href="http://dx.doi.org/10.1097/00003246-200008000-00009">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d24269e2951 class=n-a></a>Bonten MJ, Bergmans DC, Stobberingh EE, <i> et al.</i>: Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. <i>Am J Respir Crit Care Med.</i> 1997; <b>156</b>(6): 1820–4. <a target=xrefwindow id=d24269e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/9412561">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2965 href="http://dx.doi.org/10.1164/ajrccm.156.6.9610117">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d24269e2974 class=n-a></a>Timsit JF, Cheval C, Gachot B, <i> et al.</i>: Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. <i>Intensive Care Med.</i> 2001; <b>27</b>(4): 640–7. <a target=xrefwindow id=d24269e2985 href="http://www.ncbi.nlm.nih.gov/pubmed/11398689">PubMed Abstract </a> | <a target=xrefwindow id=d24269e2988 href="http://dx.doi.org/10.1007/s001340000840">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d24269e2997 class=n-a></a>Leone M, Bourgoin A, Cambon S, <i> et al.</i>: Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. <i>Crit Care Med.</i> 2003; <b>31</b>(2): 462–7. <a target=xrefwindow id=d24269e3008 href="http://www.ncbi.nlm.nih.gov/pubmed/12576952">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3011 href="http://dx.doi.org/10.1097/01.CCM.0000050298.59549.4A">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d24269e3021 class=n-a></a>Raman K, Nailor MD, Nicolau DP, <i> et al.</i>: Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. <i>Crit Care Med.</i> 2013; <b>41</b>(7): 1656–63. <a target=xrefwindow id=d24269e3032 href="http://www.ncbi.nlm.nih.gov/pubmed/23528805">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3035 href="http://dx.doi.org/10.1097/CCM.0b013e318287f713">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d24269e3044 class=n-a></a>Zahar JR, Timsit JF, Garrouste-Orgeas M, <i> et al.</i>: Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. <i>Crit Care Med.</i> 2011; <b>39</b>(8): 1886–95. <a target=xrefwindow id=d24269e3055 href="http://www.ncbi.nlm.nih.gov/pubmed/21516036">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3058 href="http://dx.doi.org/10.1097/CCM.0b013e31821b827c">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d24269e3067 class=n-a></a>Tabah A, Koulenti D, Laupland K, <i> et al.</i>: Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. <i>Intensive Care Med.</i> 2012; <b>38</b>(12): 1930–45. <a target=xrefwindow id=d24269e3078 href="http://www.ncbi.nlm.nih.gov/pubmed/23011531">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3081 href="http://dx.doi.org/10.1007/s00134-012-2695-9">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727319704"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3090 class=n-a></a>Decousser JW, Poirel L, Nordmann P: Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant <i>Enterobacteriaceae</i>: a focus on ß-lactam resistance. <i>Expert Rev Mol Diagn.</i> 2017; <b>17</b>(4): 327–50. <a target=xrefwindow id=d24269e3101 href="http://www.ncbi.nlm.nih.gov/pubmed/28135893">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3104 href="http://dx.doi.org/10.1080/14737159.2017.1289087">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727319704">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d24269e3117 class=n-a></a>Laupland KB, Paiva JA, Timsit JF: Focus on severe infections. <i>Intensive Care Med.</i> 2017; <b>43</b>(7): 1033–6. <a target=xrefwindow id=d24269e3125 href="http://www.ncbi.nlm.nih.gov/pubmed/28501950">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3128 href="http://dx.doi.org/10.1007/s00134-017-4835-8">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725312139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3137 class=n-a></a>Douglas IS, Price CS, Overdier KH, <i> et al.</i>: Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia. <i>Am J Respir Crit Care Med.</i> 2015; <b>191</b>(5): 566–73. <a target=xrefwindow id=d24269e3148 href="http://www.ncbi.nlm.nih.gov/pubmed/25585163">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3151 href="http://dx.doi.org/10.1164/rccm.201408-1468OC">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3155 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4384769">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725312139">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d24269e3169 class=n-a></a>Roberts JA, Taccone FS, Lipman J: Understanding PK/PD. <i>Intensive Care Med.</i> 2016; <b>42</b>(11): 1797–1800. <a target=xrefwindow id=d24269e3177 href="http://www.ncbi.nlm.nih.gov/pubmed/26334756">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3180 href="http://dx.doi.org/10.1007/s00134-015-4032-6">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d24269e3189 class=n-a></a>Weiss E, Essaied W, Adrie C, <i> et al.</i>: Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials. <i>Crit Care.</i> 2017; <b>21</b>(1): 162. <a target=xrefwindow id=d24269e3200 href="http://www.ncbi.nlm.nih.gov/pubmed/28655326">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3203 href="http://dx.doi.org/10.1186/s13054-017-1755-5">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3207 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5488424">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d24269e3216 class=n-a></a>McKinnon PS, Paladino JA, Schentag JJ: Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (<i>T</i>&gt;MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. <i>Int J Antimicrob Agents.</i> 2008; <b>31</b>(4): 345–51. <a target=xrefwindow id=d24269e3227 href="http://www.ncbi.nlm.nih.gov/pubmed/18313273">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3230 href="http://dx.doi.org/10.1016/j.ijantimicag.2007.12.009">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d24269e3239 class=n-a></a>Chow KM, Hui AC, Szeto CC: Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. <i>Eur J Clin Microbiol Infect Dis.</i> 2005; <b>24</b>(10): 649–53. <a target=xrefwindow id=d24269e3247 href="http://www.ncbi.nlm.nih.gov/pubmed/16261307">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3250 href="http://dx.doi.org/10.1007/s10096-005-0021-y">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d24269e3259 class=n-a></a>Roberts JA, Lefrant JY, Lipman J: What's new in pharmacokinetics of antimicrobials in AKI and RRT? <i>Intensive Care Med.</i> 2017; <b>43</b>(6): 904–6. <a target=xrefwindow id=d24269e3267 href="http://www.ncbi.nlm.nih.gov/pubmed/28386727">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3270 href="http://dx.doi.org/10.1007/s00134-017-4789-x">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726070424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3279 class=n-a></a>Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, <i> et al.</i>: Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. <i>Intensive Care Med.</i> 2016; <b>42</b>(10): 1535–45. <a target=xrefwindow id=d24269e3290 href="http://www.ncbi.nlm.nih.gov/pubmed/26754759">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3293 href="http://dx.doi.org/10.1007/s00134-015-4188-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726070424">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d24269e3307 class=n-a></a>Martínez JA, Cobos-Trigueros N, Soriano A, <i> et al.</i>: Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. <i>Antimicrob Agents Chemother.</i> 2010; <b>54</b>(9): 3590–6. <a target=xrefwindow id=d24269e3318 href="http://www.ncbi.nlm.nih.gov/pubmed/20585123">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3321 href="http://dx.doi.org/10.1128/AAC.00115-10">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2934963">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5472964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3334 class=n-a></a>Kumar A, Zarychanski R, Light B, <i> et al.</i>: Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. <i>Crit Care Med.</i> 2010; <b>38</b>(9): 1773–85. <a target=xrefwindow id=d24269e3345 href="http://www.ncbi.nlm.nih.gov/pubmed/20639750">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3348 href="http://dx.doi.org/10.1097/CCM.0b013e3181eb3ccd">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5472964">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d24269e3361 class=n-a></a>Boyer A, Gruson D, Bouchet S, <i> et al.</i>: Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. <i>Drug Saf.</i> 2013; <b>36</b>(4): 217–30. <a target=xrefwindow id=d24269e3372 href="http://www.ncbi.nlm.nih.gov/pubmed/23508544">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3375 href="http://dx.doi.org/10.1007/s40264-013-0031-0">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727434245"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3384 class=n-a></a>Ong DSY, Frencken JF, Klein Klouwenberg PMC, <i> et al.</i>: Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study. <i>Clin Infect Dis.</i> 2017; <b>64</b>(12): 1731–6. <a target=xrefwindow id=d24269e3395 href="http://www.ncbi.nlm.nih.gov/pubmed/28329088">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3398 href="http://dx.doi.org/10.1093/cid/cix186">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727434245">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d24269e3411 class=n-a></a>Planquette B, Timsit JF, Misset BY, <i> et al.</i>: <i>Pseudomonas aeruginosa</i> ventilator-associated pneumonia. predictive factors of treatment failure. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(1): 69–76. <a target=xrefwindow id=d24269e3425 href="http://www.ncbi.nlm.nih.gov/pubmed/23641973">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3429 href="http://dx.doi.org/10.1164/rccm.201210-1897OC">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d24269e3438 class=n-a></a>de Lastours V, Chau F, Roy C, <i> et al.</i>: Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. <i>J Antimicrob Chemother.</i> 2014; <b>69</b>(12): 3393–400. <a target=xrefwindow id=d24269e3449 href="http://www.ncbi.nlm.nih.gov/pubmed/25063781">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3452 href="http://dx.doi.org/10.1093/jac/dku283">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d24269e3462 class=n-a></a>Armand-Lefèvre L, Angebault C, Barbier F, <i> et al.</i>: Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. <i>Antimicrob Agents Chemother.</i> 2013; <b>57</b>(3): 1488–95. <a target=xrefwindow id=d24269e3473 href="http://www.ncbi.nlm.nih.gov/pubmed/23318796">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3476 href="http://dx.doi.org/10.1128/AAC.01823-12">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3480 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3591916">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d24269e3489 class=n-a></a>Balakrishnan I, Awad-El-Kariem FM, Aali A, <i> et al.</i>: Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae. <i>J Antimicrob Chemother.</i> 2011; <b>66</b>(11): 2628–31. <a target=xrefwindow id=d24269e3500 href="http://www.ncbi.nlm.nih.gov/pubmed/21810837">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3503 href="http://dx.doi.org/10.1093/jac/dkr317">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d24269e3512 class=n-a></a>Vardakas KZ, Rellos K, Triarides NA, <i> et al.</i>: Colistin loading dose: evaluation of the published pharmacokinetic and clinical data. <i>Int J Antimicrob Agents.</i> 2016; <b>48</b>(5): 475–84. <a target=xrefwindow id=d24269e3523 href="http://www.ncbi.nlm.nih.gov/pubmed/27743779">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3526 href="http://dx.doi.org/10.1016/j.ijantimicag.2016.08.009">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d24269e3535 class=n-a></a>Niederman MS, Chastre J, Corkery K, <i> et al.</i>: BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. <i>Intensive Care Med.</i> 2012; <b>38</b>(2): 263–71. <a target=xrefwindow id=d24269e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/22147112">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3549 href="http://dx.doi.org/10.1007/s00134-011-2420-0">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727038190"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3558 class=n-a></a>Kollef MH, Ricard JD, Roux D, <i> et al.</i>: A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial. <i>Chest.</i> 2017; <b>151</b>(6): 1239–46. <a target=xrefwindow id=d24269e3569 href="http://www.ncbi.nlm.nih.gov/pubmed/27890714">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3572 href="http://dx.doi.org/10.1016/j.chest.2016.11.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727038190">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d24269e3585 class=n-a></a>Kollef MH: COUNTERPOINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? No. <i>Chest.</i> 2017; <b>151</b>(4): 740–3. <a target=xrefwindow id=d24269e3593 href="http://www.ncbi.nlm.nih.gov/pubmed/27916619">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3596 href="http://dx.doi.org/10.1016/j.chest.2016.11.007">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726885128"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3606 class=n-a></a>Bassetti M, Luyt CE, Nicolau DP, <i> et al.</i>: Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. <i>Ann Intensive Care.</i> 2016; <b>6</b>(1): 35. <a target=xrefwindow id=d24269e3617 href="http://www.ncbi.nlm.nih.gov/pubmed/27090532">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3620 href="http://dx.doi.org/10.1186/s13613-016-0140-x">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4835402">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726885128">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727361929"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3637 class=n-a></a>Solé-Lleonart C, Rouby JJ, Blot S, <i> et al.</i>: Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults: A Systematic Review and Meta-analysis. <i>Anesthesiology.</i> 2017; <b>126</b>(5): 890–908. <a target=xrefwindow id=d24269e3648 href="http://www.ncbi.nlm.nih.gov/pubmed/28248714">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3651 href="http://dx.doi.org/10.1097/ALN.0000000000001570">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727361929">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725440816"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3664 class=n-a></a>Zampieri FG, Nassar AP Jr, Gusmao-Flores D, <i> et al.</i>: Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. <i>Crit Care.</i> 2015; <b>19</b>(1): 150. <a target=xrefwindow id=d24269e3675 href="http://www.ncbi.nlm.nih.gov/pubmed/25887226">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3678 href="http://dx.doi.org/10.1186/s13054-015-0868-y">Publisher Full Text </a> | <a target=xrefwindow id=d24269e3682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4403838">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725440816">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d24269e3695 class=n-a></a>Rattanaumpawan P, Lorsutthitham J, Ungprasert P, <i> et al.</i>: Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. <i>J Antimicrob Chemother.</i> 2010; <b>65</b>(12): 2645–9. <a target=xrefwindow id=d24269e3706 href="http://www.ncbi.nlm.nih.gov/pubmed/20876621">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3709 href="http://dx.doi.org/10.1093/jac/dkq360">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13485036"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3718 class=n-a></a>Choi EY, Huh JW, Lim CM, <i> et al.</i>: Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. <i>Intensive Care Med.</i> 2011; <b>37</b>(4): 639–47. <a target=xrefwindow id=d24269e3729 href="http://www.ncbi.nlm.nih.gov/pubmed/21253703">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3732 href="http://dx.doi.org/10.1007/s00134-011-2130-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13485036">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d24269e3745 class=n-a></a>Patel N, Pai MP, Rodvold KA, <i> et al.</i>: Vancomycin: we can't get there from here. <i>Clin Infect Dis.</i> 2011; <b>52</b>(8): 969–74. <a target=xrefwindow id=d24269e3756 href="http://www.ncbi.nlm.nih.gov/pubmed/21460308">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3759 href="http://dx.doi.org/10.1093/cid/cir078">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13923967"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3769 class=n-a></a>Wunderink RG, Niederman MS, Kollef MH, <i> et al.</i>: Linezolid in methicillin-resistant <i>Staphylococcus aureus</i> nosocomial pneumonia: a randomized, controlled study. <i>Clin Infect Dis.</i> 2012; <b>54</b>(5): 621–9. <a target=xrefwindow id=d24269e3783 href="http://www.ncbi.nlm.nih.gov/pubmed/22247123">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3787 href="http://dx.doi.org/10.1093/cid/cir895">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13923967">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2669962"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3800 class=n-a></a>Bouadma L, Luyt CE, Tubach F, <i> et al.</i>: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. <i>Lancet.</i> 2010; <b>375</b>(9713): 463–74. <a target=xrefwindow id=d24269e3811 href="http://www.ncbi.nlm.nih.gov/pubmed/20097417">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3814 href="http://dx.doi.org/10.1016/S0140-6736(09)61879-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2669962">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727154069"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24269e3827 class=n-a></a>Klompas M, Li L, Menchaca JT, <i> et al.</i>: Ultra-Short-Course Antibiotics for Patients With Suspected Ventilator-Associated Pneumonia but Minimal and Stable Ventilator Settings. <i>Clin Infect Dis.</i> 2017; <b>64</b>(7): 870–6. <a target=xrefwindow id=d24269e3838 href="http://www.ncbi.nlm.nih.gov/pubmed/28034888">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3841 href="http://dx.doi.org/10.1093/cid/ciw870">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727154069">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d24269e3854 class=n-a></a>Luyt CE, Guérin V, Combes A, <i> et al.</i>: Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. <i>Am J Respir Crit Care Med.</i> 2005; <b>171</b>(1): 48–53. <a target=xrefwindow id=d24269e3865 href="http://www.ncbi.nlm.nih.gov/pubmed/15447947">PubMed Abstract </a> | <a target=xrefwindow id=d24269e3868 href="http://dx.doi.org/10.1164/rccm.200406-746OC">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2061.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2061.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France<br/> <sup>2</sup> Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat University Hospital, Paris, France<br/> <p> <div class=margin-bottom> Jean-Francois Timsit <br/> <span>Roles: </span> Conceptualization, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Wafa Esaied <br/> <span>Roles: </span> Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Mathilde Neuville <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Lila Bouadma <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Bruno Mourvillier <br/> <span>Roles: </span> Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2061/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Nov 2017, 6:2061 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12222.1">https://doi.org/10.12688/f1000research.12222.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Timsit JF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13232 data-id=12222 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12222.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2061/v1/pdf?article_uuid=8f44c118-e840-42de-a2a0-d50f99c85a16" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12222.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Timsit JF, Esaied W, Neuville M <em>et al.</em> Update on ventilator-associated pneumonia [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2061 (<a href="https://doi.org/10.12688/f1000research.12222.1" target=_blank>https://doi.org/10.12688/f1000research.12222.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12222 id=mobile-track-article-signin-12222 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12222?target=/articles/6-2061.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13232 /> <input name=articleId type=hidden value=12222 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Saad Nseir</strong>, ICU, Lille Univ Hosp, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Michael Klompas</strong>, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, USA; Department of Medicine, Brigham and Women's Hospital, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2061.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2061.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28432-28401></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28431-28400></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2061/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Nov 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Saad Nseir</strong>, ICU, Lille Univ Hosp, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael Klompas</strong>, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, USA; Department of Medicine, Brigham and Women's Hospital, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2061.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2061/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Update on ventilator-associated pneumonia".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2061/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2061/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2061/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Timsit JF et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2061/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2061",
            templates : {
                twitter : "Update on ventilator-associated pneumonia. Timsit JF et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2061/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Update on ventilator-associated pneumonia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Update on ventilator-associated pneumonia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12222/13232")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13232");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28400": 0,
                           "28401": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "493cf917-31d0-4655-9051-d98291601163";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2061.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2061.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2061.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2061.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2061.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>